Tempus AI, USC Form Strategic Precision Medicine Partnership

MT Newswires Live04-23

Tempus AI (TEM) and the Keck School of Medicine of USC said Thursday they established a collaboration to advance artificial intelligence applications in healthcare delivery and clinical research.

The arrangement targets operational upgrades for more than 1.5 million annual patient appointments throughout the university's Southern California medical network, the companies said.

The health system will incorporate advanced molecular analysis into standard clinical procedures to facilitate personalized treatment plans, they said.

This will allow automated screening systems to match eligible individuals with experimental therapies alongside software designed to identify patient management deficiencies, the companies added.

Shares of the company were down over 5% in Thursday trading.

Price: 52.37, Change: -3.14, Percent Change: -5.66

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment